Patents Assigned to Naurex, Inc.
  • NMDA receptor modulators and prodrugs, salts, and uses thereof
    Patent number: 10590167
    Abstract: Disclosed are compounds having enhanced potency in the modulation of NMDA receptor activity. Such compounds are contemplated for use in the treatment of diseases and disorders, such as learning, cognitive activities, and analgesia, particularly in alleviating and/or reducing neuropathic pain. Orally available formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.
    Type: Grant
    Filed: July 24, 2017
    Date of Patent: March 17, 2020
    Assignee: Naurex, Inc.
    Inventor: Amin Khan
  • N-methyl-D-aspartate receptor modulators and methods of making and using same
    Patent number: 9994614
    Abstract: Disclosed are compounds having enhanced potency in the modulation of NMDA receptor activity. Such compounds are contemplated for use in the treatment of diseases and disorders, such as learning, cognitive activities, and analgesia, particularly in alleviating and/or reducing neuropathic pain. Orally available formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.
    Type: Grant
    Filed: July 24, 2015
    Date of Patent: June 12, 2018
    Assignee: Naurex, Inc.
    Inventor: M. Amin Khan
  • NMDA receptor modulators and prodrugs, salts, and uses thereof
    Patent number: 9745342
    Abstract: Disclosed are compounds having enhanced potency in the modulation of NMD A receptor activity. Such compounds are contemplated for use in the treatment of diseases and disorders, such as learning, cognitive activities, and analgesia, particularly in alleviating and/or reducing neuropathic pain. Orally available formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.
    Type: Grant
    Filed: October 27, 2014
    Date of Patent: August 29, 2017
    Assignee: Naurex, Inc.
    Inventor: Amin Khan
  • SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF
    Publication number: 20150368252
    Abstract: Disclosed are compounds having enhanced potency in the modulation of NMD A receptor activity. Such compounds are contemplated for use in the treatment of conditions such as depression and related disorders. Orally available formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.
    Type: Application
    Filed: January 29, 2014
    Publication date: December 24, 2015
    Applicant: NAUREX, INC.
    Inventors: John A. Lowe, III, M. Amin Khan
  • Hydroxamic Acid Derivatives, Preparation and Therapeutic Uses Thereof
    Publication number: 20140045943
    Abstract: Disclosed are amino alkyl/aryl hydroxamic acid compounds and pharmaceutical compositions containing such compounds. The disclosed compositions are useful as therapeutics for degenerative diseases in mammal.
    Type: Application
    Filed: March 1, 2013
    Publication date: February 13, 2014
    Applicant: Naurex, Inc.
    Inventor: Naurex, Inc.